AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimrus M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Cagrus Biopharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimrus M 1mg/500mg Tablet SR

Diabetol Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to manage them using a fast-acting glucose source like sugary foods or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimrus M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimrus M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimrus M 1mg/500mg Extended-Release Tablet with a meal.

Common Side effects of Glimrus M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimrus M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrus M 1mg/500mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

How Glimrus M 1mg/500mg Tablet SR works:

Glimepiride/Metformin 1mg/500mg Extended-Release tablets (Glimrus M) combine two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, inhibiting intestinal glucose absorption, and improving insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glimrus M 1mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimrus M 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimrus M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimrus M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. The medication is contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glimrus M 1mg/500mg Tablet SR, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a low dose; however, its use is contraindicated in those with severe hepatic dysfunction. Medical advice is recommended.

What if you forget to take Glimrus M 1mg/500mg Tablet SR :

Should you forget to take a Glimrus M 1mg/500mg SR tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimrus M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimrus M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Glimrus M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimrus M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimrus M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimrus M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimrus M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glimrus M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimrus M 1mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimrus M 1mg/500mg Table...
53
MRP 65
18% off